Fraud Blocker Peptide Research Library | Licensed Peptides
2 for 1 sale You pick the free one Any vial, any size. NO CODE, NO LIMITS. Extended sale ends in 3d 20h 27m 46s

Need help? Call Or Text us, and a team member will be happy to assist you. +1 (855) 322-2214

The Licensed Peptides research library is written and maintained by the Licensed Peptides research team. Articles summarise the published in-vitro and preclinical literature on the compounds Licensed Peptides supplies for laboratory research. They are written to a research-use-only standard: no dosing guidance, no human-use claims, and factual statements traced to the study they come from. Every article is reviewed for accuracy against the cited studies by Samuel Sarmiento, MD, MPH, MBA.

More about who writes and reviews this library

Search the Articles

Categories

Recent Posts

Articles by Licensed Peptides

  • ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

1810, 2025

Peptide Science in 2024: Research Overview

By |10/18/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Peptides have been a cornerstone of therapeutic innovation since insulin therapy was introduced in the 1920s. Over sixty peptide-based therapies...

1810, 2025

Comparative Analysis: MK 677 and MK 2866

By |10/18/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction MK 677 and MK 2866 are commonly grouped within the category of selective androgen receptor modulators (SARMs). However,...

1810, 2025

Follistatin: Research Overview

By |10/18/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction Follistatin is a regulatory glycoprotein primarily recognized for its role in modulating muscle growth and tissue development. It...

1710, 2025

B7-33: Preclinical Research Overview

By |10/17/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. Introduction B7-33 is a synthetic therapeutic candidate initially developed at Monash University, Australia. Its design was based on targeting...

1710, 2025

Comparative Overview of MK-677 and LGD-4033

By |10/17/2025|General Peptide Information|

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law. MK-677 and LGD-4033 Both MK-677 and LGD-4033 have been studied for their potential to support musculoskeletal health, particularly in...

Stay Ahead of the Curve

Get exclusive updates on events, promotions, and special offers.

You cannot copy content of this page